U.S. Physical Therapy, Inc. (USPH) to Issue Quarterly Dividend of $0.44 on June 14th

U.S. Physical Therapy, Inc. (NYSE:USPH) declared a quarterly dividend on Tuesday, May 7th, Zacks reports. Shareholders of record on Thursday, May 23rd will be given a dividend of 0.44 per share on Friday, June 14th. This represents a $1.76 annualized dividend and a yield of 1.68%. The ex-dividend date of this dividend is Wednesday, May 22nd.

U.S. Physical Therapy has raised its dividend by an average of 75.2% annually over the last three years and has increased its dividend every year for the last 5 years. U.S. Physical Therapy has a payout ratio of 57.0% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect U.S. Physical Therapy to earn $3.06 per share next year, which means the company should continue to be able to cover its $1.76 annual dividend with an expected future payout ratio of 57.5%.

U.S. Physical Therapy Stock Performance

Shares of USPH traded up $1.06 on Thursday, reaching $104.98. 22,159 shares of the stock traded hands, compared to its average volume of 68,791. The firm has a market cap of $1.58 billion, a price-to-earnings ratio of 77.76, a P/E/G ratio of 4.99 and a beta of 1.39. U.S. Physical Therapy has a 12 month low of $78.08 and a 12 month high of $124.11. The stock’s 50-day moving average price is $105.34 and its 200-day moving average price is $96.37. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.28 and a quick ratio of 2.28.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings data on Tuesday, May 7th. The company reported $0.51 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.58 by ($0.07). The company had revenue of $155.70 million for the quarter, compared to analyst estimates of $153.30 million. U.S. Physical Therapy had a return on equity of 8.52% and a net margin of 4.67%. The business’s revenue was up 4.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.59 earnings per share. Equities analysts forecast that U.S. Physical Therapy will post 2.77 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, insider Eric Joseph Williams sold 1,500 shares of the stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $104.96, for a total transaction of $157,440.00. Following the sale, the insider now owns 19,314 shares in the company, valued at $2,027,197.44. The transaction was disclosed in a filing with the SEC, which is available at this link. In other news, insider Eric Joseph Williams sold 1,500 shares of U.S. Physical Therapy stock in a transaction on Monday, March 4th. The stock was sold at an average price of $104.96, for a total value of $157,440.00. Following the transaction, the insider now directly owns 19,314 shares in the company, valued at approximately $2,027,197.44. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Carey P. Hendrickson sold 1,800 shares of U.S. Physical Therapy stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $107.28, for a total transaction of $193,104.00. Following the completion of the sale, the chief financial officer now owns 21,186 shares of the company’s stock, valued at $2,272,834.08. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 10,829 shares of company stock worth $1,141,535. 1.70% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several equities research analysts have issued reports on USPH shares. Barrington Research restated an “outperform” rating and set a $122.00 price objective on shares of U.S. Physical Therapy in a research report on Thursday. JPMorgan Chase & Co. increased their price target on U.S. Physical Therapy from $99.00 to $117.00 and gave the stock an “overweight” rating in a research report on Wednesday, March 13th. Finally, StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Monday, March 18th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $125.67.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.